Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Shikha Sundaram

Concepts (217)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
25
2025
751
4.530
Why?
Biliary Atresia
9
2024
162
2.690
Why?
Fatty Liver
5
2026
252
2.110
Why?
Sarcopenia
4
2023
100
2.090
Why?
Non-alcoholic Fatty Liver Disease
10
2024
265
2.040
Why?
Liver Diseases
3
2025
304
1.650
Why?
Pediatric Obesity
3
2026
635
1.190
Why?
Cholestasis
4
2025
217
1.120
Why?
End Stage Liver Disease
2
2021
84
1.060
Why?
Muscle, Skeletal
2
2026
1818
0.880
Why?
Human Growth Hormone
1
2025
46
0.880
Why?
Muscular Atrophy
1
2025
88
0.850
Why?
Child
37
2025
22693
0.790
Why?
Bariatric Surgery
2
2025
250
0.730
Why?
Sleep Apnea, Obstructive
2
2018
300
0.690
Why?
Obesity, Morbid
1
2025
287
0.680
Why?
Hepatoblastoma
1
2022
52
0.670
Why?
Hepatopulmonary Syndrome
2
2021
23
0.660
Why?
Malnutrition
1
2021
87
0.630
Why?
Hypoxia
3
2018
1211
0.620
Why?
Carcinoma, Hepatocellular
2
2022
370
0.560
Why?
Liver
8
2025
1864
0.520
Why?
Liver Failure, Acute
2
2024
78
0.510
Why?
Continuous Positive Airway Pressure
1
2018
91
0.510
Why?
Hypertension, Portal
1
2017
66
0.470
Why?
Liver Neoplasms
2
2022
776
0.460
Why?
Severity of Illness Index
7
2022
2921
0.460
Why?
Adolescent
17
2026
22557
0.450
Why?
Absorptiometry, Photon
2
2026
278
0.420
Why?
Waiting Lists
4
2021
251
0.420
Why?
Humans
48
2026
146342
0.400
Why?
Preoperative Care
1
2017
396
0.400
Why?
Body Mass Index
5
2026
2458
0.400
Why?
Graft Survival
6
2022
523
0.380
Why?
Oxidative Stress
2
2018
1369
0.380
Why?
Infant
13
2025
10114
0.350
Why?
Obesity
4
2022
3131
0.350
Why?
Nutritional Status
3
2025
346
0.350
Why?
Postoperative Complications
4
2025
3034
0.340
Why?
Alanine Transaminase
2
2025
151
0.300
Why?
Metabolic Syndrome
2
2013
364
0.300
Why?
Metabolism, Inborn Errors
1
2008
42
0.270
Why?
Fructose
2
2022
132
0.260
Why?
Biomarkers
5
2024
4340
0.260
Why?
Female
23
2026
79499
0.260
Why?
F2-Isoprostanes
2
2018
21
0.260
Why?
Eosinophilic Esophagitis
2
2025
333
0.260
Why?
Infant Mortality
1
2008
127
0.260
Why?
Male
23
2026
73396
0.260
Why?
Living Donors
4
2022
216
0.260
Why?
Portoenterostomy, Hepatic
3
2022
42
0.250
Why?
Quality of Life
3
2023
3200
0.250
Why?
Bile Acids and Salts
1
2008
163
0.250
Why?
Child, Preschool
14
2025
11913
0.240
Why?
Body Composition
3
2026
689
0.240
Why?
Retrospective Studies
15
2025
17438
0.240
Why?
Insulin Resistance
3
2026
1247
0.240
Why?
Treatment Outcome
8
2025
11821
0.230
Why?
Chronic Disease
2
2025
1827
0.230
Why?
Alagille Syndrome
2
2024
28
0.230
Why?
Cholestasis, Intrahepatic
2
2023
29
0.230
Why?
Nutritional Support
1
2025
39
0.220
Why?
alpha-Fetoproteins
1
2024
42
0.200
Why?
Growth Differentiation Factor 15
1
2024
44
0.200
Why?
Insulin-Like Growth Factor I
1
2025
320
0.190
Why?
Bone Diseases, Metabolic
1
2023
60
0.190
Why?
Cross-Sectional Studies
4
2025
5899
0.190
Why?
Elasticity Imaging Techniques
1
2022
59
0.170
Why?
Survival Rate
4
2017
2092
0.170
Why?
Hepatic Veins
1
2021
28
0.170
Why?
Airway Extubation
1
2022
60
0.170
Why?
Dietary Carbohydrates
1
2022
146
0.170
Why?
Immunosuppressive Agents
2
2017
829
0.170
Why?
Abdominal Fat
1
2021
51
0.170
Why?
Vaccination
2
2020
1449
0.170
Why?
Endoscopy, Digestive System
2
2025
141
0.160
Why?
Vascular Malformations
1
2021
53
0.160
Why?
Health Services Accessibility
2
2021
1107
0.160
Why?
Infant, Newborn
7
2024
6460
0.160
Why?
Longitudinal Studies
2
2025
3017
0.160
Why?
Metabolic Diseases
1
2021
114
0.160
Why?
Portal Vein
1
2021
123
0.160
Why?
Primary Graft Dysfunction
1
2020
32
0.160
Why?
Cohort Studies
5
2022
6077
0.150
Why?
gamma-Glutamyltransferase
2
2011
42
0.150
Why?
Vaccines, Attenuated
1
2020
129
0.150
Why?
Eating
1
2022
386
0.150
Why?
Remission Induction
1
2020
308
0.150
Why?
Enteral Nutrition
1
2021
212
0.150
Why?
Transplant Recipients
1
2020
177
0.140
Why?
Postoperative Care
1
2020
301
0.130
Why?
Case-Control Studies
1
2025
3647
0.130
Why?
Thioguanine
1
2017
18
0.130
Why?
Hepatitis, Autoimmune
1
2017
11
0.130
Why?
Aspartate Aminotransferases
2
2022
86
0.130
Why?
Azathioprine
1
2017
43
0.130
Why?
Practice Patterns, Physicians'
2
2017
1408
0.130
Why?
Extracorporeal Membrane Oxygenation
1
2021
370
0.130
Why?
Emotional Adjustment
1
2017
18
0.120
Why?
Glucose
1
2022
1053
0.120
Why?
Anesthetics, Intravenous
1
2017
67
0.120
Why?
Adiposity
1
2021
533
0.120
Why?
Tissue and Organ Procurement
1
2020
305
0.120
Why?
Pediatrics
2
2016
1124
0.120
Why?
Propofol
1
2017
86
0.120
Why?
Family Relations
1
2017
87
0.120
Why?
Societies, Medical
1
2020
907
0.120
Why?
Blood Glucose
1
2026
2360
0.110
Why?
Aldehydes
1
2016
140
0.110
Why?
Nicardipine
1
2015
6
0.110
Why?
Respiratory Syncytial Virus Infections
1
2017
141
0.110
Why?
Prevalence
3
2025
2861
0.110
Why?
Prenatal Exposure Delayed Effects
1
2022
665
0.110
Why?
Neoplasm Recurrence, Local
1
2022
1160
0.110
Why?
Food Hypersensitivity
1
2017
165
0.110
Why?
Healthcare Disparities
1
2021
733
0.100
Why?
Communicable Diseases
1
2017
166
0.100
Why?
Immunization
1
2016
376
0.100
Why?
Tacrolimus
1
2015
192
0.100
Why?
Gastroenterology
1
2016
187
0.100
Why?
Hyperuricemia
1
2013
47
0.100
Why?
Multivariate Analysis
2
2017
1543
0.100
Why?
Dietary Sucrose
1
2013
49
0.100
Why?
Health Policy
1
2017
399
0.100
Why?
Magnetic Resonance Imaging
1
2026
3926
0.100
Why?
Sweetening Agents
1
2013
57
0.100
Why?
Follow-Up Studies
4
2021
5439
0.090
Why?
Uric Acid
1
2013
167
0.090
Why?
Registries
3
2022
2400
0.090
Why?
Pilot Projects
1
2018
1888
0.090
Why?
Confidence Intervals
1
2012
329
0.090
Why?
Steroids
1
2012
160
0.090
Why?
Hemochromatosis
1
2011
9
0.090
Why?
Hyperbilirubinemia
1
2011
11
0.090
Why?
Hepatic Encephalopathy
1
2011
24
0.080
Why?
International Normalized Ratio
1
2011
55
0.080
Why?
Nutrition Surveys
1
2012
270
0.080
Why?
Parenteral Nutrition
1
2012
102
0.080
Why?
Regression Analysis
1
2013
999
0.080
Why?
Inflammation
1
2022
2919
0.080
Why?
Herpes Simplex
1
2011
103
0.080
Why?
Reoperation
2
2015
645
0.080
Why?
Odds Ratio
1
2012
1077
0.080
Why?
Length of Stay
2
2022
1358
0.070
Why?
Models, Statistical
1
2013
669
0.070
Why?
Pruritus
1
2008
61
0.070
Why?
Prognosis
3
2024
4351
0.070
Why?
Overweight
1
2012
614
0.060
Why?
Dietary Supplements
1
2012
587
0.060
Why?
Logistic Models
1
2012
2126
0.060
Why?
Antibiotic Prophylaxis
1
2008
140
0.060
Why?
Hospitalization
1
2017
2475
0.060
Why?
Energy Intake
2
2023
507
0.060
Why?
Time Factors
1
2017
7109
0.060
Why?
Predictive Value of Tests
2
2024
2113
0.060
Why?
Pregnancy
3
2023
7230
0.050
Why?
United States
5
2021
16136
0.050
Why?
Prospective Studies
2
2021
8123
0.050
Why?
Comorbidity
1
2009
1665
0.050
Why?
Mitochondrial Diseases
1
2024
94
0.050
Why?
Sugars
1
2023
40
0.050
Why?
Fibroblast Growth Factors
1
2024
187
0.050
Why?
Plethysmography
1
2022
104
0.050
Why?
Graft Rejection
2
2017
516
0.050
Why?
Risk Factors
2
2017
10921
0.040
Why?
ROC Curve
1
2024
617
0.040
Why?
Anthropometry
1
2022
204
0.040
Why?
Vaccines
2
2017
389
0.040
Why?
Aged
1
2022
26432
0.040
Why?
Fatty Acids, Nonesterified
1
2022
154
0.040
Why?
Maternal Nutritional Physiological Phenomena
1
2023
178
0.040
Why?
Constriction, Pathologic
1
2022
240
0.040
Why?
North America
1
2022
300
0.040
Why?
Age Factors
1
2008
3347
0.040
Why?
Liver Cirrhosis
1
2022
278
0.040
Why?
Risk Assessment
2
2022
3712
0.040
Why?
Cholesterol, LDL
1
2022
363
0.040
Why?
Incidence
2
2017
2936
0.040
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2022
218
0.040
Why?
Triglycerides
1
2022
527
0.040
Why?
Birth Weight
1
2022
521
0.040
Why?
Diabetes Mellitus, Type 2
1
2013
2623
0.040
Why?
Fatigue
1
2021
363
0.030
Why?
Maintenance Chemotherapy
1
2017
41
0.030
Why?
Contraindications, Drug
1
2017
10
0.030
Why?
Respiration, Artificial
1
2022
711
0.030
Why?
Transplantation Immunology
1
2017
28
0.030
Why?
Induction Chemotherapy
1
2017
87
0.030
Why?
Diet Therapy
1
2017
36
0.030
Why?
Palivizumab
1
2016
11
0.030
Why?
Gastrointestinal Agents
1
2017
63
0.030
Why?
Young Adult
1
2013
14330
0.030
Why?
Statistics, Nonparametric
1
2017
426
0.030
Why?
Liver Failure
1
2016
79
0.030
Why?
Immunocompromised Host
1
2017
201
0.030
Why?
Diet
1
2023
1273
0.030
Why?
Canada
1
2016
432
0.030
Why?
Immunization Programs
1
2016
194
0.030
Why?
Cytochrome P-450 Enzyme System
1
2015
163
0.030
Why?
Combined Modality Therapy
1
2017
1271
0.020
Why?
Drug Interactions
1
2015
405
0.020
Why?
Drug Administration Schedule
1
2015
790
0.020
Why?
Evidence-Based Medicine
1
2016
731
0.020
Why?
Skinfold Thickness
1
2012
43
0.020
Why?
Exercise Therapy
1
2017
488
0.020
Why?
Drug Monitoring
1
2015
399
0.020
Why?
Animals
2
2013
38107
0.020
Why?
Antihypertensive Agents
1
2015
519
0.020
Why?
Weight Gain
1
2013
562
0.020
Why?
Adult
1
2013
41087
0.020
Why?
Practice Guidelines as Topic
1
2016
1591
0.020
Why?
Feeding Behavior
1
2013
692
0.020
Why?
Renal Insufficiency, Chronic
1
2013
640
0.020
Why?
Colorado
1
2017
4595
0.020
Why?
Surveys and Questionnaires
1
2016
6073
0.010
Why?
Disease Models, Animal
1
2013
4580
0.010
Why?
Cardiovascular Diseases
1
2013
2219
0.010
Why?
Sundaram's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)